Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Eliem Therapeutics Q4 EPS $(0.29) Beats $(0.38) Estimate

Eliem Therapeutics (NASDAQ:ELYM) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.38) by 23.68 percent. This is a 27.5 percent increase over losses of $(0.40) per share from
byHappy Mohamed
March 6, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Eliem Therapeutics (NASDAQ:ELYM) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.38) by 23.68 percent. This is a 27.5 percent increase over losses of $(0.40) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts